Related Experiment Video
Updated: Jul 16, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
CCR4-bearing T cells participate in autoimmune diabetes
Soon H Kim1, Mary M Cleary, Howard S Fox
1Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA.
Abstract:
Chemokine receptor expression is exquisitely regulated on T cell subsets during the course of their migration to inflammatory sites. In the present study we demonstrate that CCR4 expression marks a pathogenic population of autoimmune T cells. CCR4 was found exclusively on memory CD4(+) T cells during the progression of disease in NOD mice. Cells expressing the CCR4 ligand TARC (thymus- and activation-regulated chemokine) were detected within infiltrated islets from prediabetic mice. Interestingly, neutralization of macrophage-derived chemokine (MDC) with Ab caused a significant reduction of CCR4-positive T cells within the pancreatic infiltrates and inhibited the development of insulitis and diabetes. Furthermore, enhanced recruitment of CCR4-bearing cells in NOD mice resulting from transgenic expression of MDC resulted in acceleration of clinical disease. Cumulatively, the results demonstrate that CCR4-bearing T cells participate in the development of such tissue-driven autoimmune reactions.
Insights
Chemokine receptor CCR4 identifies pathogenic autoimmune T cells. Targeting its ligand, macrophage-derived chemokine (MDC), reduces T cell infiltration and prevents autoimmune diabetes development in NOD mice.
Area of Science:
- Immunology
- Autoimmunity
- T cell biology
Background:
- Chemokine receptor expression on T cells is crucial for migration to inflammatory sites.
- Identifying specific T cell subsets involved in autoimmune diseases is essential for therapeutic development.
Purpose of the Study:
- To investigate the role of chemokine receptor CCR4 in T cell pathogenicity during autoimmune disease progression.
- To determine the involvement of CCR4 ligands, TARC and MDC, in autoimmune T cell recruitment and disease development.
Main Methods:
- Flow cytometry to analyze CCR4 expression on CD4+ T cells in NOD mice.
- Detection of CCR4 ligand TARC in pancreatic islets.
- Administration of antibodies to neutralize MDC and assess its effect on insulitis and diabetes.
- Transgenic expression of MDC to evaluate its impact on CCR4-bearing cell recruitment and disease acceleration.
Main Results:
- CCR4 was exclusively expressed on memory CD4+ T cells during disease progression in NOD mice.
- TARC, a CCR4 ligand, was found in islets of prediabetic mice.
- Neutralization of MDC significantly reduced CCR4-positive T cells in pancreatic infiltrates, inhibiting insulitis and diabetes.
- Enhanced MDC expression accelerated clinical disease by increasing CCR4-bearing cell recruitment.
Conclusions:
- CCR4 marks a pathogenic population of autoimmune T cells.
- The CCR4-MDC axis plays a critical role in the recruitment of T cells to pancreatic islets.
- Targeting the CCR4-MDC interaction offers a potential therapeutic strategy for autoimmune diabetes.
More Related Videos
11:31High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
10:03Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease